Hunan Fangsheng Pharmaceutical Co., Ltd. (603998.SS)
CNY 10.84
(0.18%)
CNY 10.84
(0.18%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 912.55 Million CNY | -9.11% |
| 2022 | 995.25 Million CNY | 15.7% |
| 2021 | 860.21 Million CNY | 24.16% |
| 2020 | 692.79 Million CNY | 0.01% |
| 2019 | 692.72 Million CNY | 3.51% |
| 2018 | 669.25 Million CNY | 97.4% |
| 2017 | 339.02 Million CNY | 87.26% |
| 2016 | 181.04 Million CNY | 12.87% |
| 2015 | 160.39 Million CNY | 54.95% |
| 2014 | 103.51 Million CNY | 29.24% |
| 2013 | 80.09 Million CNY | 9.07% |
| 2012 | 73.42 Million CNY | 44.81% |
| 2011 | 50.7 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 250.72 Million CNY | 12.0% |
| 2024 Q2 | 262.51 Million CNY | 4.7% |
| 2024 Q3 | 256.8 Million CNY | -13.73% |
| 2023 Q3 | 205.53 Million CNY | -14.94% |
| 2023 Q1 | 233.54 Million CNY | 8.83% |
| 2023 Q2 | 241.63 Million CNY | 3.46% |
| 2023 FY | 904.57 Million CNY | -9.11% |
| 2023 Q4 | 223.85 Million CNY | 8.91% |
| 2022 FY | 995.25 Million CNY | 15.7% |
| 2022 Q4 | 214.59 Million CNY | -26.11% |
| 2022 Q3 | 290.43 Million CNY | 12.43% |
| 2022 Q2 | 258.33 Million CNY | 11.41% |
| 2022 Q1 | 231.88 Million CNY | -8.44% |
| 2021 FY | 860.21 Million CNY | 24.16% |
| 2021 Q2 | 222.91 Million CNY | 28.44% |
| 2021 Q4 | 253.24 Million CNY | 20.31% |
| 2021 Q3 | 210.49 Million CNY | -5.57% |
| 2021 Q1 | 173.55 Million CNY | -10.33% |
| 2020 Q3 | 192.23 Million CNY | 10.76% |
| 2020 Q2 | 173.56 Million CNY | 30.07% |
| 2020 Q1 | 133.44 Million CNY | -26.62% |
| 2020 FY | 692.79 Million CNY | 0.01% |
| 2020 Q4 | 193.54 Million CNY | 0.68% |
| 2019 FY | 692.72 Million CNY | 3.51% |
| 2019 Q1 | 136.29 Million CNY | -21.59% |
| 2019 Q2 | 191.54 Million CNY | 40.54% |
| 2019 Q3 | 183.01 Million CNY | -4.45% |
| 2019 Q4 | 181.86 Million CNY | -0.63% |
| 2018 Q2 | 162.91 Million CNY | 10.57% |
| 2018 FY | 669.25 Million CNY | 97.4% |
| 2018 Q4 | 173.83 Million CNY | -6.12% |
| 2018 Q3 | 185.17 Million CNY | 13.66% |
| 2018 Q1 | 147.33 Million CNY | 0.39% |
| 2017 Q2 | 69.91 Million CNY | 53.74% |
| 2017 Q3 | 76.86 Million CNY | 9.93% |
| 2017 Q4 | 146.76 Million CNY | 90.94% |
| 2017 FY | 339.02 Million CNY | 87.26% |
| 2017 Q1 | 45.47 Million CNY | -27.55% |
| 2016 Q4 | 62.76 Million CNY | 52.5% |
| 2016 Q3 | 41.15 Million CNY | -5.93% |
| 2016 FY | 181.04 Million CNY | 12.87% |
| 2016 Q1 | 33.36 Million CNY | -39.16% |
| 2016 Q2 | 43.75 Million CNY | 31.14% |
| 2015 Q2 | 37 Million CNY | 32.06% |
| 2015 Q1 | 28.01 Million CNY | -26.01% |
| 2015 FY | 160.39 Million CNY | 54.95% |
| 2015 Q4 | 54.83 Million CNY | 35.25% |
| 2015 Q3 | 40.54 Million CNY | 9.58% |
| 2014 Q3 | 23.96 Million CNY | 3.12% |
| 2014 Q1 | 18.44 Million CNY | -25.27% |
| 2014 FY | 103.51 Million CNY | 29.24% |
| 2014 Q2 | 23.23 Million CNY | 25.99% |
| 2014 Q4 | 37.86 Million CNY | 58.02% |
| 2013 Q4 | 24.68 Million CNY | 34.37% |
| 2013 Q3 | 18.36 Million CNY | 0.0% |
| 2013 FY | 80.09 Million CNY | 9.07% |
| 2012 FY | 73.42 Million CNY | 44.81% |
| 2011 FY | 50.7 Million CNY | 0.0% |